Related references
Note: Only part of the references are listed.Development of a Spray-Dried Formulation of Peptide-Dna Nanoparticles into a Dry Powder for Pulmonary Delivery Using Factorial Design
Miftakul Munir et al.
PHARMACEUTICAL RESEARCH (2022)
Dry powder inhalers of antitubercular drugs
Nidhi Nainwal et al.
TUBERCULOSIS (2022)
Dry Powder Comprised of Isoniazid-Loaded Nanoparticles of Hyaluronic Acid in Conjugation with Mannose-Anchored Chitosan for Macrophage-Targeted Pulmonary Administration in Tuberculosis
Mahwash Mukhtar et al.
PHARMACEUTICS (2022)
ATR FTIR Study of the Interaction of TiO2 Nanoparticle Films with β-Lactoglobulin and Bile Salts
N. L. Benbow et al.
LANGMUIR (2021)
A chitosan-based nanosystem as pneumococcal vaccine delivery platform
Sandra Robla et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2021)
Performance Characteristics of Breezhaler(R) and Aerolizer(R) in the Real-World Setting
Mathieu Molimard et al.
CLINICAL DRUG INVESTIGATION (2021)
Freeze-dried vs spray-dried nanoplex DPIs based on chitosan and its derivatives conjugated with hyaluronic acid for tuberculosis: In vitro aerodynamic and in silico deposition profiles
Mahwash Mukhtar et al.
EUROPEAN POLYMER JOURNAL (2021)
Inhalable nanoparticles delivery targeting alveolar macrophages for the treatment of pulmonary tuberculosis
Jayoung Chae et al.
JOURNAL OF BIOSCIENCE AND BIOENGINEERING (2021)
Mannitol Polymorphs as Carrier in DPIs Formulations: Isolation Characterization and Performance
Ayca Altay Benetti et al.
PHARMACEUTICS (2021)
The Development of an In Vitro Horizontal Diffusion Cell to Monitor Nasal Powder Penetration Inline
Peter Gieszinger et al.
PHARMACEUTICS (2021)
Inhalable locust bean gum microparticles co-associating isoniazid and rifabutin: Therapeutic assessment in a murine model of tuberculosis infection
Ana Grenha et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2020)
Development of new in vitro models of lung protease activity for investigating stability of inhaled biological therapies and drug delivery systems
Arcadia Woods et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2020)
Inhalable Spray-Dried Chondroitin Sulphate Microparticles: Effect of Different Solvents on Particle Properties and Drug Activity
Susana Rodrigues et al.
POLYMERS (2020)
Hemolysis tendency of anticancer nanoparticles changes with type of blood group antigen: An insight into blood nanoparticle interactions
Nimisha Singh et al.
MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2020)
Spray Drying for the Preparation of Nanoparticle-Based Drug Formulations as Dry Powders for Inhalation
Maria Malamatari et al.
PROCESSES (2020)
Rifabutin-Loaded Nanostructured Lipid Carriers as a Tool in Oral Anti-Mycobacterial Treatment of Crohn's Disease
Helena Rouco et al.
NANOMATERIALS (2020)
Numerical simulation of the effect of inhalation parameters, gender, age and disease severity on the lung deposition of dry powder aerosol drugs emitted by Turbuhaler®, Breezhaler® and Genuair® in COPD patients
Alpar Horvath et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
Inhalable Dry Powder of Bedaquiline for Pulmonary Tuberculosis: In Vitro Physicochemical Characterization, Antimicrobial Activity and Safety Studies
Mohammad A. M. Momin et al.
PHARMACEUTICS (2019)
Why Wait? The Case for Treating Tuberculosis with Inhaled Drugs
Miriam Braunstein et al.
PHARMACEUTICAL RESEARCH (2019)
Mycobacterium Tuberculosis and Interactions with the Host Immune System: Opportunities for Nanoparticle Based Immunotherapeutics and Vaccines
Raymonde B. Bekale et al.
PHARMACEUTICAL RESEARCH (2019)
Comparison of peak inspiratory flow rate via the Breezhaler®, Ellipta® and HandiHaler® dry powder inhalers in patients with moderate to very severe COPD: a randomized cross-over trial
Pablo Altman et al.
BMC PULMONARY MEDICINE (2018)
Formulation, optimization, and characterization of rifampicin-loaded solid lipid nanoparticles for the treatment of tuberculosis
Nimitt V. Chokshi et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2018)
High dose dry powder inhalers to overcome the challenges of tuberculosis treatment
Mohammad A. M. Momin et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)
Lipid Nanocarrier-Mediated Drug Delivery System to Enhance the Oral Bioavailability of Rifabutin
Pradip Nirbhavane et al.
AAPS PHARMSCITECH (2017)
Solvent-free protamine nanocapsules as carriers for mucosal delivery of therapeutics
Paulina Jakubiak et al.
EUROPEAN POLYMER JOURNAL (2017)
Impairment of the pulmonary function after treatment for tuberculosis: the final result of the disease?
Mikhail Ivanovich Chushkin et al.
JORNAL BRASILEIRO DE PNEUMOLOGIA (2017)
Hemocompatibility of inhaled environmental nanoparticles: Potential use of in vitro testing
Eleonore Froehlich
JOURNAL OF HAZARDOUS MATERIALS (2017)
Microencapsulated Solid Lipid Nanoparticles as a Hybrid Platform for Pulmonary Antibiotic Delivery
Diana P. Gaspar et al.
MOLECULAR PHARMACEUTICS (2017)
A critical review of approaches and limitations of inhalation bioavailability and bioaccessibility of metal(loid)s from ambient particulate matter or dust
Farzana Kastury et al.
SCIENCE OF THE TOTAL ENVIRONMENT (2017)
Continuous manufacturing of delta mannitol by cospray drying with PVP
V. Vanhoorne et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2016)
Rifabutin-loaded solid lipid nanoparticles for inhaled antitubercular therapy: Physicochemical and in vitro studies
Diana P. Gaspar et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2016)
The interaction of protamine nanocapsules with the intestinal epithelium: A mechanistic approach
Lungile Nomcebo Thwala et al.
JOURNAL OF CONTROLLED RELEASE (2016)
FTIR studies on the effect of concentration of polyethylene glycol on polimerization of Shellac
Khairuddin et al.
8TH INTERNATIONAL CONFERENCE ON PHYSICS AND ITS APPLICATIONS (ICOPIA) (2016)
Nano- and micro-based inhaled drug delivery systems for targeting alveolar macrophages
Wing-Hin Lee et al.
EXPERT OPINION ON DRUG DELIVERY (2015)
Inhalable spray-dried formulation of D-LAK antimicrobial peptides targeting tuberculosis
Philip Chi Lip Kwok et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2015)
Th1 and Th17 Cells in Tuberculosis: Protection, Pathology, and Biomarkers
I. V. Lyadova et al.
MEDIATORS OF INFLAMMATION (2015)
Improvement on dissolution rate of inclusion complex of Rifabutin drug with β-cyclodextrin
Arumugam Shanmuga Priya et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2013)
Effect of D-mannitol polymorphism in its thermal energy storage capacity when it is used as PCM
Camila Barreneche et al.
SOLAR ENERGY (2013)
Physicochemical Characterization of Complex Drug Substances: Evaluation of Structural Similarities and Differences of Protamine Sulfate from Various Sources
David Awotwe-Otoo et al.
AAPS JOURNAL (2012)
Mannitol Dry Powder for Inhalation In Patients with Cystic Fibrosis
Celeste B. Burness et al.
DRUGS (2012)
Microencapsulated chitosan nanoparticles for pulmonary protein delivery: In vivo evaluation of insulin-loaded formulations
S. Al-Qadi et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Composition of Smoke Generated by Landing Aircraft
Michael Bennett et al.
ENVIRONMENTAL SCIENCE & TECHNOLOGY (2011)
Influence of particle size on regional lung deposition - What evidence is there?
Thiago C. Carvalho et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2011)
DDSolver: An Add-In Program for Modeling and Comparison of Drug Dissolution Profiles
Yong Zhang et al.
AAPS JOURNAL (2010)
New old challenges in tuberculosis: Potentially effective nanotechnologies in drug delivery
Alejandro Sosnik et al.
ADVANCED DRUG DELIVERY REVIEWS (2010)
Rifamycins - Obstacles and opportunities
Paul A. Aristoff et al.
TUBERCULOSIS (2010)
Mannosylated nanoparticulate carriers of rifabutin for alveolar targeting
Navneet Nimje et al.
JOURNAL OF DRUG TARGETING (2009)
Rifabutin encapsulated in liposomes exhibits increased therapeutic activity in a model of disseminated tuberculosis
M. M. Gaspar et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2008)
Inhaled nanoparticles - A current review
Wei Yang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Chitosan nanoparticle-loaded mannitol microspheres:: Structure and surface characterization
Ana Grenha et al.
BIOMACROMOLECULES (2007)
Rifabutin for treating pulmonary tuberculosis
G. Davies et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2007)
Agglomerate strength and dispersion of salmeterol xinafoate from powder mixtures for inhalation
Handoko Adi et al.
PHARMACEUTICAL RESEARCH (2006)
Microencapsulated chitosan nanoparticles for lung protein delivery
A Grenha et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2005)
Formulation and characterization of spray-dried powders containing nanoparticles for aerosol delivery to the lung
JOH Sham et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2004)
The use of different sugars as fine and coarse carriers for aerosolised salbutamol sulphate
SK Tee et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2000)
Therapeutic efficacy of liposomal rifabutin in a Mycobacterium avium model of infection
MM Gaspar et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Share Paper
